After the slowest first half for European initial public offerings in more than a decade, dealmakers are banking on several large transactions to reignite the market later this year.

Medical technology company Brainlab postponed its initial public offering in Frankfurt on Tuesday, the latest deal to be shelved as Europe’s market for new listings remains cautious. Munich-based ...

Cirsa’s IPO comprises a €400m primary offering and a €53m secondary offering by LHMC Midco, a holding of Blackstone. Morgan ...

In 2024, non-household entities purchased 12,696 dwellings at market prices, representing ...

Germany's Brainlab postponed its planned initial public offering indefinitely, dealing another blow to Europe's IPO market.

Jerome Powell, the chair of the Federal Reserve has said that the US central bank... A letter written on behalf of Deel, the HR firm at the centre of a corporate espionage... The US Senate has voted ...

German medical technology company’s decision comes after car parts retailer Autodoc pushes back flotation plans ...

BERLIN (Reuters) -German medical technology firm Brainlab on Tuesday became the latest IPO candidate in the region to put ...

The CEO of German medical technology firm Brainlab said on Tuesday that geopolitical uncertainties had prompted the decision ...

Top riser on the FTSE 350 today is B&M European Value Retail SA (LSE:BME) after analysts at RBC Capital Markets joined those ...

BERLIN (Reuters) -German medical technology firm Brainlab is expected to price at 80 euros ($93.86) per share in its initial public offering planned for Thursday, according to a statement from a ...